MUSCLE INVASIVE BLADDER CANCER (MIBC)
Clinical trials for MUSCLE INVASIVE BLADDER CANCER (MIBC) explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CANCER (MIBC) trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may let bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests whether a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy can shrink HER2-positive muscle-invasive bladder cancer enough to allow patients to keep their bladder instead of having it surgically removed. About 25 adults aged 18 to 85 with …
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 17, 2026 04:42 UTC
-
Can a simple IV drip at home keep bladder cancer patients out of the hospital?
Disease control Recruiting nowThis study looks at whether giving patients IV fluids at home for four weeks after bladder cancer surgery can lower the chance of needing to go back to the hospital. About 130 adults having this surgery will be randomly assigned to either get the usual care or the usual care plus…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new treatment that delivers radiation directly to cancer cells in people with advanced solid tumors that cannot be removed by surgery. The treatment uses a special molecule to find and attach to cancer cells, then delivers a radioactive payload to destroy …
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE1, PHASE2 • Sponsor: ITM Oncologics GmbH • Aim: Disease control
Last updated May 11, 2026 20:47 UTC